Detalhe da pesquisa
1.
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452207
2.
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.
Br J Haematol
; 204(4): 1450-1458, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953476
3.
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.
Blood
; 139(18): 2747-2757, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511184
4.
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546696
5.
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Haematologica
; 108(10): 2774-2782, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078253
6.
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
Am J Hematol
; 98(2): 264-271, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588407
7.
Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial.
Haematologica
; 106(7): 1867-1875, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527951
8.
Kinome expression profiling to target new therapeutic avenues in multiple myeloma.
Haematologica
; 105(3): 784-795, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289205
9.
Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
J Enzyme Inhib Med Chem
; 35(1): 935-949, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249633
10.
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial.
Br J Haematol
; 187(3): 319-327, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31218679
11.
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.
Br J Cancer
; 118(8): 1062-1073, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500406
12.
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
JAMA
; 318(6): 557-566, 2017 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787506
13.
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Am J Hematol
; 91(4): 366-70, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689746
14.
New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships.
Bioorg Med Chem
; 24(11): 2433-40, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27094151
15.
Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Biol Blood Marrow Transplant
; 21(8): 1452-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25911579
16.
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial.
Haematologica
; 100(2): 269-74, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425691
17.
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
Haematologica
; 100(12): 1587-94, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385211
18.
Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 41(2): 696-715, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110653
19.
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 41(4): 1576-1593, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402374
20.
Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma.
Front Oncol
; 13: 1271847, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125947